Cargando…
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Tumor cells metabolize in distinct pathways compared with most normal tissue cells. The resulting tumor microenvironment would provide characteristic physiochemical conditions for selective tumor modalities. Here we introduce a concept of sequential catalytic nanomedicine for efficient tumor therapy...
Autores principales: | Huo, Minfeng, Wang, Liying, Chen, Yu, Shi, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572465/ https://www.ncbi.nlm.nih.gov/pubmed/28842577 http://dx.doi.org/10.1038/s41467-017-00424-8 |
Ejemplares similares
-
Magnesium hexacyanoferrate nanocatalysts attenuate chemodrug-induced cardiotoxicity through an anti-apoptosis mechanism driven by modulation of ferrous iron
por: Huo, Minfeng, et al.
Publicado: (2022) -
Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy
por: Ji, Penghao, et al.
Publicado: (2022) -
Catalytic Degradation of Benzene over Nanocatalysts containing Cerium and Manganese
por: Wang, Zhen, et al.
Publicado: (2016) -
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
por: Zhang, Bo, et al.
Publicado: (2017) -
Auger Electrons Constructed Active Sites on Nanocatalysts for Catalytic Internal Radiotherapy
por: Su, Weiwei, et al.
Publicado: (2020)